Observational studyAnnals of emergency medicine2026
Does Exposure to Certified Stroke Centers Affect All Communities Equitably? Stroke Patient Outcomes by Community Socioeconomic Status.
Observational study in Annals of emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Community-Level Procedure Volume and Patient Health Profiles Following PCI-Capable Facility Openings.JAMA network open · 2026Article
- Stroke Technology Diffusion in Rural Settings: Differential Exposure to Certification Levels by Community Income Levels.Neurology · 2026Article
- Social Factors Influencing Decision-Making in Intracerebral Haemorrhage: A Survey among Neurology Professionals.Cerebrovascular diseases (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
STUDY
objectiveTo determine how access, treatment, and outcomes change for patients after their community is exposed to a newly certified stroke center based on a community's disadvantage status.
methodsIn this retrospective observational study, we included Medicare Fee-for-Service patients from a national claims-based database admitted to hospitals between January 2009 and December 2019 whose primary diagnosis was acute ischemic stroke. We implemented linear probability models with community fixed effects to compare changes in outcomes when communities were exposed to newly certified stroke centers nearby relative to similar communities that did not experience stroke center expansion, controlling for patient demographics and comorbid conditions and secular trends. Outcomes included admission to a certified stroke center, receipt of thrombolytic therapy or mechanical thrombectomy, and 1-year mortality.
resultsWe analyzed 2,807,763 patients with acute ischemic stroke. Only 68% of those in disadvantaged communities had exposure to a newly certified stroke center nearby during the study period, whereas 92% of those in advantaged communities had the same exposure. In disadvantaged communities, new stroke centers were associated with a 23.1 percentage point (pp) increase in admission to a stroke center, a 0.3 pp increase in "drip-and-ship" thrombolytic therapy, a 0.2 pp decrease in thrombectomy, and no statistically significant changes in "drip-and-stay" thrombolytic therapy or 1-year mortality. In advantaged communities, new stroke centers were associated with a 4.2 pp increase in admission to a stroke center, a 0.6 pp decrease in "drip-and-ship" thrombolytic therapy, a 0.8 pp increase in "drip-and-stay" thrombolytic therapy, a 0.2 pp increase in thrombectomy, and a small reduction in 1-year mortality of 0.6 pp.
conclusionStroke center expansion has been uneven, and its effects on patient care differ by a community's socioeconomic status. These findings should guide stroke center initiatives to improve care in disadvantaged communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.